Zoster‑Related Ear Pain (Ramsay Hunt Syndrome)

What is Zoster‑Related Ear Pain (Ramsay Hunt Syndrome)?

Ramsay Hunt syndrome (RHS), also called herpes zoster oticus, is a neurological disorder caused by the reactivation of the varicella‑zoster virus (VZV) – the same virus that causes chickenpox and shingles. When VZV awakens in the facial nerve (cranial nerve VII) near the ear, it produces intense ear pain, a painful blistering rash around the ear canal, and can affect facial movement, hearing, and balance.

In everyday language, “zoster‑related ear pain” describes the sharp, burning or throbbing pain that often precedes the rash in RHS. Because the virus attacks the facial nerve and sometimes the vestibulocochlear nerve (cranial nerve VIII), patients may also experience facial weakness, ringing in the ears (tinnitus), or sudden hearing loss.

While RHS is relatively uncommon (about 5–12 % of all shingles cases), prompt recognition is essential. Early antiviral therapy dramatically improves the chance of full recovery and reduces the risk of permanent facial paralysis or hearing loss.

Common Causes

RHS itself is caused by VZV reactivation, but several factors increase the likelihood of that reactivation or mimic its presentation. The most frequent contributors are:

• Varicella‑zoster virus reactivation – the direct cause of RHS.
• Advanced age – immune surveillance declines after age 50, making shingles more common.
• Immunosuppression – HIV, organ‑transplant drugs, chemotherapy, or chronic steroids lower the body’s ability to keep VZV dormant.
• Stress – physical or emotional stress can trigger viral reactivation.
• Chronic diseases – diabetes, chronic kidney disease, or malignancy increase risk.
• Previous chickenpox infection – everyone who has had chickenpox carries latent VZV, which can later reactivate.
• Trauma to the ear or facial nerve – surgery, ear piercing, or severe ear infections may set the stage.
• Vaccination status – lack of shingles vaccine (Shingrix®) in adults ≥ 50 years leaves one vulnerable.
• Other viral infections – co‑infection with herpes simplex virus can confuse the clinical picture.
• Autoimmune disorders – conditions such as lupus or rheumatoid arthritis that require immunomodulating drugs.

Associated Symptoms

Ear pain in RHS seldom appears alone. The virus’s proximity to several cranial nerves leads to a cluster of symptoms that can develop over a few days:

• Rash or vesicles – fluid‑filled blisters on the external ear, ear canal, tongue, or scalp.
• Facial weakness or paralysis – difficulty closing the eye, drooping of the mouth, or asymmetrical facial expression (similar to Bell’s palsy).
• Hearing changes – sudden sensorineural hearing loss or muffled hearing on the affected side.
• Tinnitus – ringing, buzzing, or hissing in the ear.
• Vertigo or imbalance – sensation that the room is spinning, difficulty standing or walking.
• Dry mouth and altered taste – due to involvement of the chorda tympani branch of the facial nerve.
• Ear fullness or pressure – a sensation of blockage.
• Headache – often localized near the ear or temple.
• Fever and malaise – low‑grade fever may accompany the rash.

When to See a Doctor

Because RHS can lead to permanent facial paralysis or hearing loss, early medical evaluation is crucial. Seek care promptly if you notice any of the following:

• Severe ear pain that does not improve with over‑the‑counter analgesics.
• Development of a painful rash or blisters around the ear, mouth, or face.
• Sudden facial droop, difficulty closing one eye, or inability to smile symmetrically.
• Rapid loss of hearing or new tinnitus on the affected side.
• Persistent vertigo, dizziness, or loss of balance.
• Fever > 38 °C (100.4 °F) accompanying ear pain or rash.

Even if you suspect a simple ear infection, let your clinician know about the rash or facial weakness; this will direct appropriate testing and treatment.

Diagnosis

Diagnosing RHS involves a combination of clinical assessment and, occasionally, laboratory or imaging studies.

Clinical evaluation

• History – Onset of pain, presence of rash, facial weakness, hearing changes, and risk factors (age, immunosuppression).
• Physical examination – Inspection of the ear, external auditory canal, and oral cavity for vesicles; assessment of facial nerve function (House‑Brackmann scale); audiometric testing for hearing loss.

Laboratory tests

• Polymerase chain reaction (PCR) of vesicle fluid – Detects VZV DNA; the most specific test.
• Serology – VZV IgM/IgG may support diagnosis but is less definitive.

Imaging

• MRI with contrast – Helps rule out tumors, stroke, or other causes of facial nerve palsy if the presentation is atypical.
• CT of the temporal bone – Occasionally used to assess bony involvement when there is severe otitis.

In most cases, a characteristic rash plus facial weakness is enough for a clinical diagnosis, and treatment is started without waiting for test results.

Treatment Options

Early treatment (ideally within 72 hours of symptom onset) improves outcomes dramatically.

Antiviral therapy

• Acyclovir 800 mg five times daily for 7–10 days, or
• Valacyclovir 1 g three times daily for 7 days, or
• Famciclovir 500 mg three times daily for 7 days.

All three agents are equally effective; valacyclovir and famciclovir are often preferred for dosing convenience.

Corticosteroids

Oral prednisone (0.5 mg/kg/day, tapering over 10–14 days) reduces inflammation of the facial nerve and improves the likelihood of full facial recovery. Steroids are most beneficial when given alongside antivirals.

Pain management

• Acetaminophen or NSAIDs for mild‑moderate pain.
• Short‑course opioids only if pain is severe and unresponsive.
• Topical lidocaine or capsaicin patches may soothe localized vesicular pain.

Facial nerve care

• Eye protection (lubricating drops, ointments, and an eye patch) if eyelid closure is incomplete.
• Physical therapy – gentle facial exercises to maintain muscle tone.

Hearing and vestibular support

• Referral to an audiologist for baseline and follow‑up hearing tests.
• Vestibular rehabilitation exercises if vertigo persists.

Home care and supportive measures

• Keep the rash clean and dry; avoid picking at vesicles.
• Apply cool compresses to reduce discomfort.
• Stay hydrated and get plenty of rest to aid immune recovery.
• Use a humidifier to ease ear canal irritation.

Prevention Tips

Because RHS is a reactivation of VZV, preventing shingles is the cornerstone of prevention.

• Shingles vaccination – Adults ≥50 years should receive the recombinant zoster vaccine (Shingrix®) in a two‑dose series. Immunocompromised adults 19 years and older may also benefit.
• Maintain a healthy immune system – Balanced diet, regular exercise, adequate sleep, and stress‑reduction techniques.
• Manage chronic conditions – Keep diabetes, HIV, or other immune‑affecting diseases well‑controlled.
• Avoid smoking and excessive alcohol – Both impair immune function.
• Prompt treatment of primary chickenpox – Early antiviral therapy in children reduces the viral load that later reactivates.
• Good ear hygiene – While it does not prevent RHS, keeping the ear clean can reduce secondary bacterial infection once vesicles appear.

Emergency Warning Signs

Key Take‑aways

• Ramsay Hunt syndrome is a shingles‑related facial nerve disorder that presents with ear pain, rash, and facial weakness.
• Early antiviral and steroid therapy (within 72 hours) markedly improves recovery.
• Vaccination with Shingrix® is the most effective preventive measure for adults over 50.
• Seek prompt medical care if you develop a painful ear rash, facial droop, or sudden hearing loss.
• Red‑flag symptoms such as severe paralysis, high fever, or signs of meningitis require emergency attention.

---

References:

1. Mayo Clinic. “Ramsay Hunt syndrome.” mayoclinic.org. Accessed May 2026.
2. Cleveland Clinic. “Herpes Zoster Oticus (Ramsay Hunt Syndrome).” clevelandclinic.org. Accessed May 2026.
3. CDC. “Shingles (Herpes Zoster) Vaccine.” cdc.gov. Accessed May 2026.
4. NIH, National Institute on Deafness and Other Communication Disorders. “Ramsay Hunt Syndrome Fact Sheet.” nidcd.nih.gov. Accessed May 2026.
5. World Health Organization. “Varicella‑zoster virus infections.” who.int. Accessed May 2026.